Clinical trials
Infertile Females or Females With Ovarian Insufficiency clinical trials
Below are recruiting infertile females or females with ovarian insufficiency clinical trials, each written for real people, not researchers. We’re tracking 166 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07231510Recruiting
Chlordecone exposure and female fertility study
This study looks at how exposure to chlordecone, a chemical found in some Caribbean soils, might affect a woman's ability to get pregnant. You may be asked to share your medical history and provide samples to help us understand this link.
Pointe-à-PitreAges 18–39 - NCT07308561Recruiting
Infertility, quality of life, anxiety and AI attitudes
This study looks at how infertility treatment affects a woman's quality of life, anxiety, and views on artificial intelligence. By asking questions, researchers hope to learn more about women's experiences and feelings during treatment.
Istanbul, AtaşehirAges 18–45 - NCT07471373Recruiting
Pesticides and infertility study in endometriosis
This study looks at how pesticides might affect fertility in women with endometriosis, focusing on stress markers and gut/genital bacteria. You will provide samples and answer questions so researchers can compare women with and without endometriosis.
SalouëlAges 18–43 - NCT07524764Recruiting
Female Reproductive Health in Canadian Armed Forces
This research study explores reproductive health experiences and needs of women currently serving or who have served in the Canadian Armed Forces. Researchers are interviewing female service members, veterans, healthcare providers, and policymakers to understand challenges and improve support.
Sherbrooke, QuebecAges 18 years+ - NCT06045351RecruitingPhase 1
Vitamin D shots for women with PCOS and low vitamin D
This trial tests whether vitamin D injections can help females with polycystic ovary syndrome (PCOS) who also have low vitamin D levels. Participants will receive the injection and be monitored for changes in their condition.
Karachi, SindhAges 18–45 - NCT06686537RecruitingPhase 2
Study on metabolism and hormones in women
This study looks at how metabolism and hormones are connected in women. It tests a treatment to see if it can improve metabolic health related to the menstrual cycle.
Aurora, ColoradoAges 18–38 - NCT03252795Recruiting
Uterus transplant for women with uterine absence
This trial tests whether receiving a uterus transplant can allow someone with uterine absence to carry a pregnancy. It also looks at whether the procedure is safe for the patient and supports a future baby using frozen embryos.
GhentAges 18–38 - NCT04167748Recruiting
Genetic testing for embryos in IVF for women 35–40
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
Margate, FloridaAges 35–40 - NCT04356664RecruitingPhase 2/Phase 3
GnRH shot before frozen embryo transfer for endometriosis
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
SuresnesAges 18–36 - NCT04878224Recruiting
Look at uterine lining area in IVF outcomes
This study follows women who are having IVF/ICSI or frozen embryo transfer (FET) to see how a specific area of the uterine lining relates to pregnancy outcomes. It may help doctors better predict which embryo-transfer situations lead to better results.
LisbonAges 18–42 - NCT04880590Recruiting
Testing embryo transfer in women with a heterosexual partner
This trial is looking at women who have a heterosexual sexual relationship and are doing an embryo transfer using a frozen embryo cycle (often called FET). It may help researchers understand how sex-related factors could matter for outcomes around embryo transfer.
BarcelonaAges Any age - NCT05244967Recruiting
Study of sexually transmitted infections and female fertility impact
This study looks at how sexually transmitted infections affect female fertility. It mainly enrolls young adults to better understand patterns and outcomes over time.
LübeckAges 18–22 - NCT05358483Recruiting
Study of mothers and babies’ health factors
This study follows women planning pregnancy and their children for many years to understand what social and health factors shape outcomes for mothers and infants. Your participation may help researchers better understand risks and protective factors before and after birth.
Chicago, IllinoisAges 18–44 - NCT05421364Recruiting
Boosting your own immune cells to improve the uterine lining
This study gives a small amount of your own immune cells into the uterus to change the immune environment in the uterine lining. It aims to improve how the uterine lining supports implantation, especially for people trying to conceive with embryo transfer of normal (euploid) embryos.
Sofia, SofiaAges 20–50 - NCT05473273Recruiting
Blood test study during normal frozen embryo transfer
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05750849Recruiting
Checks progesterone levels to predict pregnancy in fertility treatment
This study looks at whether a blood progesterone level around the time of a pregnancy test during fertility treatment helps predict which patients will have an ongoing pregnancy. It may help doctors better understand who is most likely to continue developing a pregnancy during artificial cycles.
Valencia, ValenciaAges 18–50 - NCT05763498Recruiting
Uterine findings during IVF and IVF-related pregnancy outcomes
This trial looks at a specific area of the uterus during fertility treatment and how it relates to pregnancy complications. It may help improve how doctors assess risk in people using IVF or frozen embryo transfer.
Funchal, MadeiraAges 18–40 - NCT05775198Recruiting
IVF trial using your own immune cells to support embryo transfer
This trial studies whether placing your own immune cells (PBMCs) that have been adjusted with a medicine called IFN-<i>t</i> before embryo transfer can improve IVF success. It may help support the uterine environment around the time of implantation.
Sofia, SofiaAges 18–50 - NCT05969795RecruitingPhase 1
Natural embryo transfer with or without progesterone support
This Phase 1 study compares pregnancy outcomes, especially live birth, when using a natural-cycle frozen embryo transfer with an embryo that is genetically euploid (normal chromosome number) versus doing transfers without luteal (progesterone) phase support. It may help determine whether adding progesterone around ovulation improves the chance of a live birth.
Abu DhabiAges 18–40 - NCT06006091Recruiting
Letrozole for preparing the womb before embryo transfer
This study tests if a medicine called letrozole can help prepare the lining of the womb for a frozen embryo transfer. It may be an option for women under 40 who have had limited previous IVF cycles.
ShanghaiAges Up to 40 years - NCT06041204Recruiting
Thyroid hormone plus letrozole for PCOS and mild hypothyroidism
This trial tests whether adding a low-dose thyroid hormone (levothyroxine) to the standard fertility treatment letrozole improves pregnancy rates in women with both PCOS and mild hypothyroidism. It may help if you have trouble getting pregnant and have these two conditions.
CairoAges 20–40 - NCT06141135Recruiting
Genetic testing in IVF with single embryo transfer
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
Waltham, MassachusettsAges 35–40 - NCT06193135Recruiting
Comparing two ovarian stimulation medications for egg donors
This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.
Valencia, ValenciaAges 18–35 - NCT06357442Recruiting
Comparing progesterone methods for young people on estrogen therapy
This study compares two ways to give progesterone to young people on estrogen replacement therapy to see how they affect the lining of the uterus. It will help find which approach may be safer and more effective for your health.
Aurora, ColoradoAges 12–25
Hear when a new Infertile Females or Females With Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infertile females or females with ovarian insufficiency?
- Yes. Clin2 currently lists 166 recruiting infertile females or females with ovarian insufficiency studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infertile females or females with ovarian insufficiency trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infertile females or females with ovarian insufficiency trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.